Stockreport

Sage Therapeutics's depression candidate SAGE-217 shows positive treatment effect in Part A of mid-stage study [Seeking Alpha]

Sage Therapeutics, Inc.  (SAGE) 
Last sage therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sagerx.com/investor-relations
PDF Top-line data from Part A (n=13) of a Phase 2 clinical trial assessing Sage Therapeutics' (NASDAQ: SAGE ) SAGE-217 for the treatment of major depressive disor [Read more]